Abstract:Onychomycosis is the most prevalent onychopathy and it requires a correct early
diagnosis. Currently, the diagnostic gold standard is the association of direct
mycological test with culture; however, it shows variable sensitivity. The
histopathological examination of the distal nail plate, called clipping, has
shown to be an adjuvant in diagnosing onychomycosis. This is an easy-to-perform,
relatively cheap examination that is little dependent of the examiner, rapidly
provides results, has high sensitivity, and… Show more
“…Depending on the clinical presentation, nail clippings, nail plate scrapings, nail bed scrapings, and subungual scrapings may be necessary for sample collection [ 76 , 77 ]. A sterile nail clipper should be used to clip the full thickness nail plate and a sterile curette or blade should be used to obtain subungual debris [ 57 , 64 , 78 ].…”
Section: Diagnosis and Diagnostic Studiesmentioning
Background :
Onychomycosis is a common fungal infection of the nail.
Objective:
The study aimed to provide an update on the evaluation, diagnosis, and treatment of onychomycosis.
Methods:
A PubMed search was completed in Clinical Queries using the key term “onychomycosis”.
The search was conducted in May 2019. The search strategy included meta-analyses, randomized controlled
trials, clinical trials, observational studies, and reviews published within the past 20 years. The
search was restricted to English literature. Patents were searched using the key term “onychomycosis”
in www.freepatentsonline.com.
Results :
Onychomycosis is a fungal infection of the nail unit. Approximately 90% of toenail and 75%
of fingernail onychomycosis are caused by dermatophytes, notably Trichophyton mentagrophytes and
Trichophyton rubrum. Clinical manifestations include discoloration of the nail, subungual hyperkeratosis,
onycholysis, and onychauxis. The diagnosis can be confirmed by direct microscopic examination
with a potassium hydroxide wet-mount preparation, histopathologic examination of the trimmed affected
nail plate with a periodic-acid-Schiff stain, fungal culture, or polymerase chain reaction assays.
Laboratory confirmation of onychomycosis before beginning a treatment regimen should be considered.
Currently, oral terbinafine is the treatment of choice, followed by oral itraconazole. In general,
topical monotherapy can be considered for mild to moderate onychomycosis and is a therapeutic option
when oral antifungal agents are contraindicated or cannot be tolerated. Recent patents related to the
management of onychomycosis are also discussed.
Conclusion:
Oral antifungal therapies are effective, but significant adverse effects limit their use.
Although topical antifungal therapies have minimal adverse events, they are less effective than oral
antifungal therapies, due to poor nail penetration. Therefore, there is a need for exploring more effective
and/or alternative treatment modalities for the treatment of onychomycosis which are safer and
more effective.
“…Depending on the clinical presentation, nail clippings, nail plate scrapings, nail bed scrapings, and subungual scrapings may be necessary for sample collection [ 76 , 77 ]. A sterile nail clipper should be used to clip the full thickness nail plate and a sterile curette or blade should be used to obtain subungual debris [ 57 , 64 , 78 ].…”
Section: Diagnosis and Diagnostic Studiesmentioning
Background :
Onychomycosis is a common fungal infection of the nail.
Objective:
The study aimed to provide an update on the evaluation, diagnosis, and treatment of onychomycosis.
Methods:
A PubMed search was completed in Clinical Queries using the key term “onychomycosis”.
The search was conducted in May 2019. The search strategy included meta-analyses, randomized controlled
trials, clinical trials, observational studies, and reviews published within the past 20 years. The
search was restricted to English literature. Patents were searched using the key term “onychomycosis”
in www.freepatentsonline.com.
Results :
Onychomycosis is a fungal infection of the nail unit. Approximately 90% of toenail and 75%
of fingernail onychomycosis are caused by dermatophytes, notably Trichophyton mentagrophytes and
Trichophyton rubrum. Clinical manifestations include discoloration of the nail, subungual hyperkeratosis,
onycholysis, and onychauxis. The diagnosis can be confirmed by direct microscopic examination
with a potassium hydroxide wet-mount preparation, histopathologic examination of the trimmed affected
nail plate with a periodic-acid-Schiff stain, fungal culture, or polymerase chain reaction assays.
Laboratory confirmation of onychomycosis before beginning a treatment regimen should be considered.
Currently, oral terbinafine is the treatment of choice, followed by oral itraconazole. In general,
topical monotherapy can be considered for mild to moderate onychomycosis and is a therapeutic option
when oral antifungal agents are contraindicated or cannot be tolerated. Recent patents related to the
management of onychomycosis are also discussed.
Conclusion:
Oral antifungal therapies are effective, but significant adverse effects limit their use.
Although topical antifungal therapies have minimal adverse events, they are less effective than oral
antifungal therapies, due to poor nail penetration. Therefore, there is a need for exploring more effective
and/or alternative treatment modalities for the treatment of onychomycosis which are safer and
more effective.
“…Histopathological evaluation was also performed on hematoxylin-eosin and periodic acid Schiff (PAS) [2]. In the PAS, the presence of uniform septate hyphae invading the nail plate suggests dermatophyte infection, thicker tortuous wall hyphae represent nondermatophyte fungi, and conidia on the ventral surface of the lamina, especially if accompanied by buds and pseudohyphae, suggest Candida infection [13]; however, identification of the species causing the infection is not possible [14]. e isolates were identified by standard mycological procedures.…”
Psoriasis and psoriatic arthritis are chronic, relapsing, immune-based diseases. Psoriatic patients may have nail involvement in 50 to 80% of cases, and this may reach 85% in patients with joint disease, in spite of the fact that the relationship between psoriasis and onychomycosis is not well established. The aim of this study was to investigate the occurrence of onychomycosis in patients with nail disorders and diagnosis of psoriasis and psoriatic arthritis. This was a cross-sectional study in which 38 patients diagnosed with psoriasis and/or psoriatic arthritis were interviewed and had altered nail samples analysed by mycological and histopathological exams. Twenty-two (57.89%) patients had a confirmed diagnosis for onychomycosis. Seventeen (44.8%) had a positive direct mycological examination, 16 (42.1%) had positive cultures, and 12 (31.6%) were positive for fungi by histopathological examination. Dermatophytes were identified in nine (56.3%) cultures, and of these, eight were Trichophyton rubrum and one T. tonsurans. Yeasts were isolated in seven patients (43.75%), which included four Candida parapsilosis and three C. albicans. Six patients (15.78%) were not using immunosuppressive therapy, and the others were using methotrexate, etanercept, adalimumab, infliximab, secukinumab, or golimumab, in monotherapy or in combination with other drugs. The confirmed onychomycosis rate in patients using methotrexate alone was 92.8% (n = 13). We concluded that it is possible that there is a positive relationship between psoriatic disease and onychomycosis. And we highlight that it is also worth investigating in the future the possible role of immunosuppressive therapy (mainly methotrexate) as a predisposing factor for the development of fungal infections in psoriatic patients.
“…To acquire an adequate nail sample for examination, at least 4 mm of the free edge of the nail plate should be retrieved using a dual-action or heavy-duty nail nipper (66). Samples can be transported to the laboratory in a dry container or in formaldehyde (67). Softening nail samples before routine processing with solutions such as chitin-softening agent, 4% phenol or 10% Tween 40, facilitates sectioning and thus optimizes the quality of sections (66,67).…”
Section: Histopathology (Nail Clipping)mentioning
confidence: 99%
“…Samples can be transported to the laboratory in a dry container or in formaldehyde (67). Softening nail samples before routine processing with solutions such as chitin-softening agent, 4% phenol or 10% Tween 40, facilitates sectioning and thus optimizes the quality of sections (66,67). After paraffin embedding and sectioning, stains highlight presence of fungi (Figure 1D).…”
Onychomycosis is a common fungal nail infection. Accurate diagnosis is critical as onychomycosis is transmissible between humans and impacts patients' quality of life. Combining clinical examination with mycological testing ensures accurate diagnosis. Conventional diagnostic techniques, including potassium hydroxide testing, fungal culture and histopathology of nail clippings, detect fungal species within nails. New diagnostic tools have been developed recently which either improve detection of onychomycosis clinically, including dermoscopy, reflectance confocal microscopy and artificial intelligence, or mycologically, such as molecular assays. Dermoscopy is cost-effective and non-invasive, allowing clinicians to discern microscopic features of onychomycosis and fungal melanonychia. Reflectance confocal microscopy enables clinicians to observe bright filamentous septate hyphae at near histologic resolution by the bedside. Artificial intelligence may prompt patients to seek further assessment for nails that are suspicious for onychomycosis. This review evaluates the current landscape of diagnostic techniques for onychomycosis.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.